Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo

INTRODUCTION: Overactive bladder (OAB) syndrome has a negative impact on quality of life and prevalence increases with advanced age. Anticholinergics (AC) and beta-3 adrenergic agonists (β3a) are commonly prescribed medications for treatment of OAB. AC medication has been associated with dementia in...

Descripción completa

Detalles Bibliográficos
Autores principales: High, Rachel A., Danford, Jill M., Shi, Zhaoyue, Karmonik, Christof, Kuehl, Thomas J., Bird, Erin T., Khavari, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381509/
https://www.ncbi.nlm.nih.gov/pubmed/32728649
http://dx.doi.org/10.1016/j.conctc.2020.100621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381509/
https://www.ncbi.nlm.nih.gov/pubmed/32728649
http://dx.doi.org/10.1016/j.conctc.2020.100621

Ejemplares similares